Amplifon S.p.A Basic EPS 2019-2024 | AMFPF
Amplifon S.p.A annual/quarterly basic eps history and growth rate from 2019 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Amplifon S.p.A basic eps for the quarter ending September 30, 2024 was $0.00, a 100% decline year-over-year.
- Amplifon S.p.A basic eps for the twelve months ending September 30, 2024 was $0.46, a 0% increase year-over-year.
- Amplifon S.p.A annual basic eps for 2024 was $0.001B, a 7.07% decline from 2023.
- Amplifon S.p.A annual basic eps for 2023 was $0.001B, a 10.5% decline from 2022.
- Amplifon S.p.A annual basic eps for 2022 was $0.001B, a 0.96% increase from 2021.
| Amplifon S.p.A Annual Basic EPS | |
|---|---|
| 2024 | $0.70 |
| 2023 | $0.75 |
| 2022 | $0.84 |
| 2021 | $0.83 |
| 2020 | $0.52 |
| 2019 | $0.55 |
| 2018 | $0.54 |
| Amplifon S.p.A Quarterly Basic EPS | |
|---|---|
| 2024-09-30 | |
| 2024-03-31 | $0.17 |
| 2023-03-31 | $0.14 |
| 2022-03-31 | $0.15 |
| 2021-03-31 | $0.13 |
| 2020-03-31 | $0.03 |
| 2019-03-31 | $0.09 |
| 2018-12-31 | $0.22 |
| 2018-09-30 | $0.06 |
| 2018-06-30 | $0.18 |
| 2018-03-31 | $0.08 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.378B | $2.607B |
| Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.373B | 26.51 |
| Elevance Health (ELV) | United States | $87.880B | 11.34 |
| CVS Health (CVS) | United States | $87.261B | 10.85 |
| Cencora (COR) | United States | $58.118B | 20.22 |
| Natera (NTRA) | United States | $23.068B | 0.00 |
| DiDi Global (DIDIY) | China | $23.062B | 24.50 |
| Labcorp Holdings (LH) | United States | $21.972B | 17.82 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.845B | 0.00 |
| Solventum (SOLV) | United States | $13.121B | 13.89 |
| CochLear (CHEOY) | Australia | $12.902B | 0.00 |
| ICON (ICLR) | Ireland | $11.746B | 10.92 |
| Revvity (RVTY) | United States | $11.400B | 19.62 |
| Viatris (VTRS) | United States | $10.481B | 3.60 |
| Avantor (AVTR) | United States | $9.172B | 13.33 |
| HealthEquity (HQY) | United States | $9.059B | 39.68 |
| Medpace Holdings (MEDP) | United States | $9.021B | 23.96 |
| Sonic Healthcare (SKHHY) | Australia | $8.561B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.452B | 14.60 |
| Caris Life Sciences,�Inc (CAI) | $6.798B | 0.00 | |
| Bausch + Lomb (BLCO) | Canada | $4.602B | 27.10 |
| BrightSpring Health Services (BTSG) | United States | $4.147B | 38.05 |
| Sotera Health (SHC) | United States | $3.156B | 17.93 |
| Surgery Partners (SGRY) | United States | $2.849B | 37.05 |
| Alignment Healthcare (ALHC) | United States | $2.770B | 0.00 |
| Concentras Parent (CON) | United States | $2.637B | 15.24 |
| GeneDx Holdings (WGS) | United States | $2.634B | 101.44 |
| Organon (OGN) | United States | $2.516B | 2.67 |
| PACS (PACS) | United States | $1.969B | 0.00 |
| Ardent Health (ARDT) | United States | $1.954B | 8.33 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| Premier (PINC) | United States | $1.806B | 13.71 |
| GoodRx Holdings (GDRX) | United States | $1.779B | 35.57 |
| Teladoc Health (TDOC) | United States | $1.528B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.235B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.233B | 9.38 |
| CareDx (CDNA) | United States | $1.088B | 16.99 |
| Agilon Health (AGL) | United States | $0.952B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.791B | 7.41 |
| Nutex Health (NUTX) | United States | $0.692B | 10.47 |
| LifeMD (LFMD) | United States | $0.619B | 0.00 |
| Embecta (EMBC) | United States | $0.566B | 3.82 |
| InnovAge Holding (INNV) | United States | $0.498B | 0.00 |
| Enhabit (EHAB) | United States | $0.488B | 40.17 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Omada Health (OMDA) | $0.471B | 0.00 | |
| Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.459B | 10.33 |
| So-Young (SY) | China | $0.314B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.262B | 0.00 |
| Beauty Health (SKIN) | United States | $0.241B | 0.00 |
| Oncology Institute (TOI) | United States | $0.183B | 0.00 |
| DocGo (DCGO) | United States | $0.160B | 26.17 |
| Pheton Holdings (PTHL) | China | $0.121B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| KindlyMD (NAKA) | United States | $0.083B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.027B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |